{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T07:02:10Z","timestamp":1795071730458,"version":"4.10.2"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:p>\n                    Human papillomavirus (HPV)-negative cervical carcinomas are uncommon and typically encompass unusual histologic subtypes. Mesonephric adenocarcinoma is one such subtype. Mesonephric tumors in the female genital tract are thought to arise from Wolffian remnants, and are extremely rare tumors with widely variable morphology. Sarcomatoid dedifferentiation has been previously described in a few cases, but other forms of dedifferentiation have not been reported. Neuroendocrine carcinoma of the cervix (e.g. small cell carcinoma) is associated with HPV infection, typically HPV 18. These tumors often arise in association with a conventional epithelial component such as squamous cell carcinoma or usual-type endocervical adenocarcinoma. We describe a case of mesonephric adenocarcinoma of the uterine cervix associated with an HPV-negative high-grade neuroendocrine carcinoma at the morphologic and immunophenotypic level, for which we performed targeted massively parallel sequencing analysis of the 2 elements. Both components shared identical mutations in\n                    <jats:italic toggle=\"yes\">U2AF1<\/jats:italic>\n                    p.R156H (c.467G&gt;A) and\n                    <jats:italic toggle=\"yes\">GATA3<\/jats:italic>\n                    p.M422fs (c.1263dupG), as well as\n                    <jats:italic toggle=\"yes\">MYCN<\/jats:italic>\n                    amplification. In addition, the neuroendocrine carcinoma harbored\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">MST1R<\/jats:italic>\n                    mutations not present in the mesonephric carcinoma. Our data suggest a clonal origin of the 2 components of this rare entity, rather than a collision tumor.\n                  <\/jats:p>","DOI":"10.1097\/pgp.0000000000000306","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T12:47:39Z","timestamp":1471351659000},"page":"76-89","source":"Crossref","is-referenced-by-count":34,"title":["Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular Pathogenesis"],"prefix":"10.1097","volume":"36","author":[{"given":"Marcela S.","family":"Cavalcanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Schultheis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah F.","family":"DeLair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Weigelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginger","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M.","family":"Lichtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/PAS.0b013e31821534b9","article-title":"Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus","volume":"35","author":"Park","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/IGC.0b013e3182981bdc","article-title":"Absence of human papillomavirus infection and activation of PI3K-AKT pathway in cervical clear cell carcinoma","volume":"23","author":"Ueno","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/00000478-199510000-00006","article-title":"Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component","volume":"19","author":"Clement","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00000478-200405000-00006","article-title":"Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases","volume":"28","author":"Bague","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1746-1596-8-74","article-title":"Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: a case report and review of the literature","volume":"8","author":"Meguro","year":"2013","journal-title":"Diagn Pathol"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/PGP.0000000000000088","article-title":"Mesonephric carcinosarcoma involving uterine cervix and vagina: report of 2 cases with immunohistochemical positivity For PAX2, PAX8, and GATA-3","volume":"33","author":"Roma","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/path.2368","article-title":"Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast","volume":"215","author":"Marchio","year":"2008","journal-title":"J Pathol"},{"issue":"Pt 7","key":"R9-20230824","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1099\/0022-1317-80-7-1725","article-title":"Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines","volume":"80","author":"Meissner","year":"1999","journal-title":"J Gen Virol"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/00000478-199012000-00002","article-title":"Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases","volume":"14","author":"Ferry","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2214\/ajr.131.3.499","article-title":"Mesonephric duct remnants (Gartner\u2019s duct)","volume":"131","author":"Wepfer","year":"1978","journal-title":"AJR Am J Roentgenol"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000478-200103000-00013","article-title":"Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings","volume":"25","author":"Silver","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R15-20230824","first-page":"7012","article-title":"Mesonephric adenocarcinoma of the uterine corpus","volume":"7","author":"Wu","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31824a72c6","article-title":"Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-beta","volume":"36","author":"Kenny","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R17-20230824","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/PGP.0000000000000102","article-title":"Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix","volume":"33","author":"Goyal","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/PGP.0000000000000167","article-title":"Differential expression patterns of GATA3 in uterine mesonephric and nonmesonephric lesions","volume":"34","author":"Roma","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/PAS.0000000000000471","article-title":"GATA3 is a sensitive and specific marker of benign and malignant mesonephric lesions in the lower female genital tract","volume":"39","author":"Howitt","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00004347-199307000-00011","article-title":"Mesonephric adenocarcinoma of the uterine cervix with focal endocrine cell differentiation","volume":"12","author":"Stewart","year":"1993","journal-title":"Int J Gynecol Pathol"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2559.1985.tb02430.x","article-title":"Endocrine cells in the female genital tract","volume":"9","author":"Fetissof","year":"1985","journal-title":"Histopathology"},{"key":"R22-20230824","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/AOG.0b013e318173570b","article-title":"Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix","volume":"111","author":"Chen","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R23-20230824","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0046-8177(03)00284-3","article-title":"P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix","volume":"34","author":"Masumoto","year":"2003","journal-title":"Hum Pathol"},{"key":"R24-20230824","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2559.2007.02790.x","article-title":"Biomarker-assisted diagnosis of ovarian, cervical and pulmonary small cell carcinomas: the role of TTF-1, WT-1 and HPV analysis","volume":"51","author":"Carlson","year":"2007","journal-title":"Histopathology"},{"key":"R25-20230824","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/01.pgp.0000185406.85685.df","article-title":"p16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix","volume":"25","author":"Horn","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"R26-20230824","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/PAI.0b013e3181ae7240","article-title":"Detection of HPV-DNA by a PCR-based method in formalin-fixed, paraffin-embedded tissue from rare endocervical carcinoma types","volume":"18","author":"Nofech-Mozes","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ygyno.2014.05.017","article-title":"Small cell carcinoma of the gynecologic tract: a multifaceted spectrum of lesions","volume":"134","author":"Atienza-Amores","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R28-20230824","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.2396","article-title":"Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer","volume":"44","author":"Peifer","year":"2012","journal-title":"Nat Genet"},{"key":"R29-20230824","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2162-3619-4-2","article-title":"Distinct genetic alterations in small cell carcinoma from different anatomic sites","volume":"4","author":"Zheng","year":"2015","journal-title":"Exp Hematol Oncol"},{"key":"R30-20230824","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"R31-20230824","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/modpathol.2015.103","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract","volume":"28","author":"Mirkovic","year":"2015","journal-title":"Mod Pathol"},{"key":"R32-20230824","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1177\/1947601911404223","article-title":"GATA transcription factors and cancer","volume":"1","author":"Zheng","year":"2010","journal-title":"Genes Cancer"},{"key":"R33-20230824","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/45590","article-title":"Functional recognition of the 3\u2019 splice site AG by the splicing factor U2AF35","volume":"402","author":"Wu","year":"1999","journal-title":"Nature"},{"key":"R34-20230824","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ng.1031","article-title":"Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes","volume":"44","author":"Graubert","year":"2012","journal-title":"Nat Genet"},{"key":"R35-20230824","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"Imielinski","year":"2012","journal-title":"Cell"},{"key":"R36-20230824","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"R37-20230824","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"R38-20230824","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1158\/1541-7786.MCR-13-0536","article-title":"The N-myc oncogene: maximizing its targets, regulation, and therapeutic potential","volume":"12","author":"Beltran","year":"2014","journal-title":"Mol Cancer Res"},{"key":"R39-20230824","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/his.12622","article-title":"Myc protein expression correlates with MYC amplification in small-cell lung carcinoma","volume":"67","author":"Hwang","year":"2015","journal-title":"Histopathology"},{"key":"R40-20230824","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s00432-014-1769-1","article-title":"MYC amplification is associated with poor survival in small cell lung cancer: a chromogenic in situ hybridization study","volume":"140","author":"Alves Rde","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"R41-20230824","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fonc.2014.00060","article-title":"The many faces of neuroendocrine differentiation in prostate cancer progression","volume":"4","author":"Terry","year":"2014","journal-title":"Front Oncol"},{"key":"R42-20230824","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1158\/0008-5472.CAN-07-1320","article-title":"FBXW7\/hCDC4 is a general tumor suppressor in human cancer","volume":"67","author":"Akhoondi","year":"2007","journal-title":"Cancer Res"},{"key":"R43-20230824","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.immuni.2007.04.018","article-title":"Notch directly regulates Gata3 expression during T helper 2 cell differentiation","volume":"27","author":"Fang","year":"2007","journal-title":"Immunity"},{"key":"R44-20230824","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.cell.2013.05.041","article-title":"The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability","volume":"153","author":"King","year":"2013","journal-title":"Cell"},{"key":"R45-20230824","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/iep.12021","article-title":"IRS2 is a candidate driver oncogene on 13q34 in colorectal cancer","volume":"94","author":"Day","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"R46-20230824","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1158\/0008-5472.CAN-12-3385","article-title":"Therapeutic destruction of insulin receptor substrates for cancer treatment","volume":"73","author":"Reuveni","year":"2013","journal-title":"Cancer Res"},{"key":"R47-20230824","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1245\/ASO.2005.08.013","article-title":"RON, a tyrosine kinase receptor involved in tumor progression and metastasis","volume":"12","author":"Camp","year":"2005","journal-title":"Ann Surg Oncol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004347-201701000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T21:22:48Z","timestamp":1692825768000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004347-201701000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000306","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}